Halozyme Therapeutics Inc. (NASDAQ: HALO) stock fell -1.24% on Thursday to $40.52 against a previous-day closing price of $41.03. With 0.94 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.05 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $41.61 whereas the lowest price it dropped to was $40.38. The 52-week range on HALO shows that it touched its highest point at $59.46 and its lowest point at $29.85 during that stretch. It currently has a 1-year price target of $51.80. Beta for the stock currently stands at 1.24.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HALO was up-trending over the past week, with a rise of 3.53%, but this was down by -7.95% over a month. Three-month performance surged to 22.90% while six-month performance rose 1.17%. The stock lost -1.89% in the past year, while it has lost -28.79% so far this year. A look at the trailing 12-month EPS for HALO yields 1.70 with Next year EPS estimates of 3.70. For the next quarter, that number is 0.74. This implies an EPS growth rate of -47.60% for this year and 38.52% for next year. EPS is expected to grow by 26.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 26.00%.
Float and Shares Shorts:
At present, 131.73 million HALO shares are outstanding with a float of 130.57 million shares on hand for trading. On Aug 30, 2023, short shares totaled 6.84 million, which was 5.19% higher than short shares on Jul 30, 2023. In addition to Dr. Helen I. Torley M.B. Ch. B., M.R.C.P. as the firm’s Pres, CEO & Director, Ms. Nicole LaBrosse serves as its Sr. VP & CFO.
Other institutions hold 55.11% of HALO, in contrast to 39.33% held by mutual funds. Shares owned by individuals account for 18.23%. As the largest shareholder in HALO with 11.43% of the stake, BlackRock Fund Advisors holds 15,051,523 shares worth 15,051,523. A second-largest stockholder of HALO, The Vanguard Group, Inc., holds 12,753,289 shares, controlling over 9.69% of the firm’s shares. Artisan Partners LP is the third largest shareholder in HALO, holding 7,459,511 shares or 5.67% stake. With a 3.21% stake in HALO, the iShares Core S&P Mid Cap ETF is the largest stakeholder. A total of 4,228,708 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 3.09% of HALO stock, is the second-largest Mutual Fund holder. It holds 4,073,062 shares valued at 174.98 million. Vanguard Small Cap Index Fund holds 2.59% of the stake in HALO, owning 3,415,558 shares worth 146.73 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, HALO reported revenue of $152.37M and operating income of $34.06M. The EBITDA in the recently reported quarter was $46.61M and diluted EPS was $0.16.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HALO since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With HALO analysts setting a high price target of $72.00 and a low target of $28.00, the average target price over the next 12 months is $51.80. Based on these targets, HALO could surge 77.69% to reach the target high and fall by -30.9% to reach the target low. Reaching the average price target will result in a growth of 27.84% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded HALO stock several times over the past three months with 12 Buys and 10 Sells. In these transactions, 100,000 shares were bought while 90,000 shares were sold. The number of buy transactions has increased to 51 while that of sell transactions has risen to 62 over the past year. The total number of shares bought during that period was 470,234 while 442,667 shares were sold.